ClinicalTrials.Veeva

Menu

Identifying Patients With Unrecognized Treatable Diabetic Macular Edema

E

Elman Retina Group

Status

Unknown

Conditions

Diabetic Macular Edema

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01934920
Elman-01

Details and patient eligibility

About

This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam. The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ability to provide written informed consent and comply with study assessments for the full duration of the study
  • Age > 18 years
  • Patient related considerations
  • Patients with diabetes mellitus
  • Disease related considerations
  • Diabetes mellitus

Exclusion criteria

  • Prior admission screening within twelve months.
  • Inability to sit for evaluation

Trial contacts and locations

2

Loading...

Central trial contact

Jennifer Belz

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems